Your browser doesn't support javascript.
loading
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial.
Tripathy, Debu; Tolaney, Sara M; Seidman, Andrew D; Anders, Carey K; Ibrahim, Nuhad; Rugo, Hope S; Twelves, Chris; Diéras, Véronique; Müller, Volkmar; Du, Yining; Currie, Sue L; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L; Cortés, Javier.
Afiliação
  • Tripathy D; The University of Texas MD Anderson Cancer Center, Houston.
  • Tolaney SM; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Seidman AD; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Anders CK; Duke Cancer Institute, Durham, North Carolina.
  • Ibrahim N; The University of Texas MD Anderson Cancer Center, Houston.
  • Rugo HS; University of California, San Francisco.
  • Twelves C; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, England.
  • Diéras V; Centre Eugène Marquis, Rennes, France.
  • Müller V; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Du Y; Nektar Therapeutics, San Francisco, California.
  • Currie SL; Nektar Therapeutics, San Francisco, California.
  • Hoch U; Nektar Therapeutics, San Francisco, California.
  • Tagliaferri M; Nektar Therapeutics, San Francisco, California.
  • Hannah AL; Nektar Therapeutics, San Francisco, California.
  • Cortés J; International Breast Cancer Center, Quironsalud Group, Barcelona, Spain.
JAMA Oncol ; 8(7): 1047-1052, 2022 07 01.
Article em En | MEDLINE | ID: mdl-35552364

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias da Mama Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias da Mama Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article